Recent Research Funding

Our faculty secure major research grants from various National Institutes of Health as well as private sources.

  • Programmable Hydrogels for Optimized Human Oligodendrocyte Transplantation in Demyelinating Disease. Fraser Sim (Co-Principal Investigator). National Institute of Neurological Disorders and Stroke (NINDS). $2,930,725. 7/1/2023-6/1/2028.
  • Modulation of oligodendrocyte development by voltage-operated calcium channels. Pablo Paez (Principal Investigator). National Institute of Neurological Disorders and Stroke (NINDS). $1,993,750. 12/1/2021-11/1/2027.
  • Role of Microglia in Prenatal ethanol exposure-induced Impairment of Endocannabinoid Signaling. Roh-Yu Shen (Principal Investigator). NIAAA. 9/1/2022-8/1/2027.
  • Role of microglia in prenatal ethanol exposure-induced impairment of endocannabinoid signaling. Samir Haj-Dahmane (Co-Investigator). NIH. $1,813,263. 9/1/2022-6/1/2027.
  • The role of the nociceptor endocytosis in inflammatory pain. Arin Bhattacharjee (Principal Investigator). National Institute of Neurological Disorders & Stroke. $1,907,471. 6/1/2022-5/1/2027.
  • Research training on alcohol etiology and treatment. Caroline Bass (Contributor). NIH, NIAAA. $575,310. 2/16/2022-4/1/2026.
  • OSHA Outreach Center Cooperative Agreement. Paul Kostyniak (Principal Investigator). OSHA. 10/1/2010-9/1/2025.
  • Superfund Health & Safety Training Cooperative Agreement-HWWT & HDPT. Paul Kostyniak (Principal Investigator). NIEHS. $109,312. 8/1/2010-7/1/2025.
  • University at Buffalo, SUNY Occupational Safety & Health Project. Paul Kostyniak (Co-Investigator). NIOSH. $123,837. 7/1/2010-6/1/2025.
  • Synaptic transport of endocannabinoids in the brain. Roh-Yu Shen (Co-Principal Investigator). NIH/NIMH. $2,349,284. 3/1/2021-3/1/2025.
  • Clinical and Translational Science Award (KL2): Mentored Career Development Award. Margarita Dubocovich (Principal Investigator). NIH/NCATS. $2,706,260. 8/1/2015-12/1/2024.
  • Clinical and Translational Science Award: Buffalo Clinical and Translational Research Center. Margarita Dubocovich (Co-Investigator). National Center for Advancing Translational Sciences. $19,936,155. 8/1/2015-12/1/2024.
  • Overcoming human-specific obstacles to successful remyelination in multiple sclerosis. Fraser Sim (Principal Investigator). Department of Defense (CDMRP). 9/1/2021-10/1/2024.
  • Tau accumulation in the pedunculopontine tegmentum as an early node in Progressive Supranuclear Palsy pathogenesis. Stewart Clark (Principal Investigator). NINDS. 8/1/2020-8/1/2024.
  • Prenatal Tobacco and Cannabis Exposure: A Translational Study. Panayotis Thanos (Principal Investigator). NIH. 2/15/2022-8/1/2024.
  • Induction of Oligodendrocyte Progenitor Cell Differentiation by Blocking Store-Operated Oscillatory Calcium Release. Fraser Sim (Principal Investigator). Department of Defense (CDMRP). $238,056. 7/1/2022-6/1/2024.
  • Disrupting ion channel scaffolding to treat neuropathic pain. Arin Bhattacharjee (Principal Investigator). National Institute of Neurological Disorders and Stroke. $1,901,925. 9/1/2019-3/1/2024.
  • TAAR1 agonists for nicotine addiction. Jun-Xu Li (Principal Investigator). USPHS NIH. $1,986,083. 4/1/2019-2/1/2024.
  • The peripheral nervous system: a window into Krabbe disease. Pablo Paez (Co-Investigator). National Institute of Neurological Disorders and Stroke (NINDS). $1,929,000. 2/1/2019-1/1/2024.
  • Small molecule biased agonists of the NPS receptor. Stewart Clark (Principal Investigator). NIMH. 12/1/2019-10/1/2023.